Results 171 to 180 of about 506,403 (348)
Ecography, EarlyView.Projected warming and drying raise concerns about the resilience of stress‐adapted ecosystems, including the Brazilian Campo Rupestre, an exceptionally biodiverse mountaintop grassland mosaic on ancient, nutrient‐poor substrates. Here, we combine field‐based trait data and long‐term remote sensing to assess the functional structure and temporal ...
Renata Maia +5 more
wiley +1 more source
Contemporary China Studies in Japan: mainstream approaches and challenges [PDF]
, 2017 Kazuko Môri
openalex +1 more source
Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York
ESC Heart Failure, Volume 12, Issue 2, Page 819-831, April 2025.Abstract Background Seasonal variations have been observed in heart failure (HF) hospitalization. Numerous explanatory mechanisms have been proposed, but no prior studies have examined potential contributors directly. Our objective was to identify specific factors that could contribute to seasonal variability using a large longitudinal dataset of HF ...
Prerna Gupta +5 more
wiley +1 more source
A rendezvous between Noh and Contemporary music (Session Ⅱ Western vibrations of Noh: Shifts, Translation, Interpretations, The Proceedings of the 14th Symposium on Global perspectives in Japanese Studies) [PDF]
, 2013 法子 馬場, Noriko BABA
openalex
Japanese videogames in English translation: a study of contemporary subtitling practices
, 2022 Matteo Fabbretti
openalex +2 more sources
ESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy +15 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies +23 more
wiley +1 more source
Polymeric Transcatheter Heart Valves: Are We Entering the Next Era of TAVR Durability? [PDF]
JACC AsiaShirai S, Hayashi M, Ishizu K.
europepmc +1 more source